Articles from: EuroIntervention
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
RT @sbrugaletta: First-in-human use of the NeVa mechanical thrombectomy device for patients with #ACS https://t.co/sEfPTgm7w5 @PCRonline @m… - view on twitter
More coverage:
#acs
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
RT @Ortega_Paz: Maximal stent expansion of contemporary DES https://t.co/XJx76WBRyI @EuroInterventio @PCRonline #PCI #CHIP https://t.co/XJx76WBRyI - view on twitter
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
In the FLOWER MI trial, including patients presenting with STEMI and MVD, cost-effectiveness and cost-utility were in favour of angiography-guided PCI compared with FFR-guided PCI. #EAPCI https://t.co/PvTN0rh3Hm https://t.co/PvTN0rh3Hm - view on twitter
More coverage:
#eapci
Mashup Score:17
EuroInterventionThe Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
Transfemoral transcatheter aortic valve implantation has demonstrated similar results as well as superiority over surgical aortic valve replacement in low-to-high surgical risk elderly patients with tricuspid aortic valve stenosis. #EAPCI #TAVI https://t.co/kxfHY2zaOX https://t.co/kxfHY2zaOX - view on twitter
Mashup Score:31
EuroInterventionThe Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
In this #TAVI study, patients with bicuspid aortic valves had similar satisfactory three-year clinical outcomes, persistent valve haemodynamic improvement, and obvious cardiac reverse remodelling compared with patients with tricuspid aortic valves. #EAPCI https://t.co/X1nwk3zq3N https://t.co/X1nwk3zq3N - view on twitter
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
RT @sbrugaletta: First-in-human use of the NeVa mechanical thrombectomy device for patients with #ACS https://t.co/sEfPTgm7w5 @PCRonline @m… - view on twitter
More coverage:
#acs
Mashup Score:1
EuroInterventionThe Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
First-in-human use of the NeVa mechanical thrombectomy device for patients with #ACS https://t.co/sEfPTgm7w5 @PCRonline @mirvatalasnag #EAPCI @escardio https://t.co/sEfPTgm7w5 - view on twitter
Mashup Score:11
EuroInterventionThe Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
Selecting the optimal device for patients deemed to be at HBR and requiring a short course of DAPT remains challenging. A report modelling device-related safety and effectiveness in a cohort defined by the standardized ARC-HBR criteria. #EIJBestOF https://t.co/0xTJtO7eGF https://t.co/0xTJtO7eGF - view on twitter
More coverage:
#eijbestof
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
-
The PROMISE trial is a randomised, multicentre trial that will include 180 MINOCA patients randomised 1:1 to a "precision-medicine approach"versus a "standard of care” approach. https://t.co/Wofgl1531M https://t.co/Wofgl1531M - view on twitter
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions...
#CardioTwitter @CardioIAN https://t.co/W1C8wjrXre - view on twitter